[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fA1HTwucRdFX8s0i7AxUp0u1jDdJit41nKrkunY5ENEk":3},{"answer":4,"createTime":5,"id":6,"options":7,"origin":13,"question":17,"related":18,"source":29,"type":30},[],"2023-11-11 19:42:30",105142200,[8,9,10,11,12],"在预防、诊断、治疗疾病或调节生理功能过程中,人接受高于正常剂量的药物时出现的有伤害的和与用药目的无关的反应","在预防、诊断、治疗疾病或调节生理功能过程中,药物尚未达到正常剂量时出现的任何有伤害的和与用药目的无关的反应","在预防、诊断、治疗疾病或调节生理功能过程中,药物出现的各种有伤害的和与用药目的无关的反应","在预防、诊断、治疗疾病或调节生理功能过程中,人接受正常剂量的药物时出现的任何有伤害的和与用药目的无关的反应","在预防、诊断、治疗疾病或调节生理功能过程中,同时服用多种药物时出现的任何有伤害的和与用药目的无关的反应",{"courseId":14,"courseImg":15,"courseName":16},"c7e66b38d867ca46401061eb2ae95791","https:\u002F\u002Ftihai-oss-cloud.itihey.com\u002Fimg\u002F48eba3395437dd881b1b9275a0ad1028.png","药事管理与法规","世界卫生组织对药物不良反应的定义是( )",[19,31,40,49,58,67,76,79,88,98],{"answer":20,"createTime":21,"id":22,"options":23,"question":28,"source":29,"type":30},[],"2023-11-11 19:42:29",105142194,[24,25,26,27],"量变异常型药品不良反应","质变异常型药品不良反应","迟现型药品不良反应","药物相互作用型药品不良","根据ADR的分类,反应停事件属于( )","v1",0,{"answer":32,"createTime":5,"id":33,"options":34,"question":39,"source":29,"type":30},[],105142195,[35,36,37,38],"2010年12月31日","2010年7月1日","2011年12月31日","2011年7月1日","《药品不良反应报告和监测管理办法》是哪一年开始实施( )",{"answer":41,"createTime":5,"id":42,"options":43,"question":48,"source":29,"type":30},[],105142196,[44,45,46,47],"是指药品在正常用法用量下出现的与用药目的无关的有害反应","是指药品在使用过程中出现的与用药目的无关的有害反应","是指药品在使用过程中出现出现的有害反应","是指合格药品在正常用法用量下出现的与用药目的无关的有害反应","药品不良反应( )",{"answer":50,"createTime":5,"id":51,"options":52,"question":57,"source":29,"type":30},[],105142197,[53,54,55,56],"5","10","15","20","药品生产、经营企业和医疗机构发现或者获知新的、严重的药品不良反应应当在( )日内报告",{"answer":59,"createTime":5,"id":60,"options":61,"question":66,"source":29,"type":30},[],105142198,[62,63,64,65],"地方各级药品监督管理部门","国家药品监督管理局","各级卫生行政部门","国家药品不良反应监测中心","( )主管全国药品不良反应报告和监测工作",{"answer":68,"createTime":5,"id":69,"options":70,"question":75,"source":29,"type":30},[],105142199,[71,72,73,74],"新的","严重的","所有","一般","新药监测期内的国产药品应当报告该药品的( )不良反应",{"answer":77,"createTime":5,"id":6,"options":78,"question":17,"source":29,"type":30},[],[8,9,10,11,12],{"answer":80,"createTime":5,"id":81,"options":82,"question":87,"source":29,"type":30},[],105142201,[83,84,85,86],"首次进口 5 年以内的进口药品","已受理注册申请的新药","已过新药监测期的国产药品","处于Ⅲ期临床试验的药物","根据《药品不良反应报告和监测管理办法》,应报告所有的不良反应的是( )",{"answer":89,"createTime":5,"id":90,"options":91,"question":97,"source":29,"type":30},[],105142202,[92,93,94,95,96],"报告制度","评价、分析制度","登记制度","自愿呈报制度","核查制度","根据《药品不良反应报告和监测管理办法》,国家对药品不良反应实行",{"answer":99,"createTime":5,"id":100,"options":101,"question":107,"source":29,"type":30},[],105142203,[102,103,104,105,106],"15日内","立即","1日内","3日内","5日内","《药品不良反应报告和监测管理办法》规定,药品发生群体不良反应的报告时限是《药品不良反应报告和监测管理办法》规定,药品发生群体不良反应的报告时限是()"]